Dubuque Bank & Trust’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $811K | Buy |
1,510
+176
| +13% | +$90.7K | 0.11% | 95 |
|
|
2023
Q2 | $626K | Sell |
1,334
-47
| -3% | -$19.7K | 0.08% | 116 |
|
|
2023
Q1 | $474K | Sell |
1,381
-18
| -1% | -$6.07K | 0.06% | 132 |
|
|
2022
Q4 | $512K | Buy |
1,399
+70
| +5% | +$24.8K | 0.07% | 123 |
|
|
2022
Q3 | $430K | Sell |
1,329
-515
| -28% | -$163K | 0.06% | 129 |
|
|
2022
Q2 | $598K | Sell |
1,844
-13
| -0.7% | -$3.9K | 0.08% | 112 |
|
|
2022
Q1 | $532K | Sell |
1,857
-140
| -7% | -$36K | 0.06% | 129 |
|
|
2021
Q4 | $552K | Sell |
1,997
-102
| -5% | -$25.9K | 0.06% | 137 |
|
|
2021
Q3 | $485K | Sell |
2,099
-151
| -7% | -$37.3K | 0.05% | 157 |
|
|
2021
Q2 | $516K | Sell |
2,250
-107
| -5% | -$21.5K | 0.06% | 160 |
|
|
2021
Q1 | $440K | Sell |
2,357
-37
| -2% | -$7.24K | 0.05% | 176 |
|
|
2020
Q4 | $404K | Buy |
+2,394
| New | +$357K | 0.05% | 174 |
|
|
2020
Q3 | – | Sell |
-1,277
| Closed | -$210K | – | 212 |
|
|
2020
Q2 | $210K | Buy |
+1,277
| New | +$196K | 0.03% | 194 |
|
|
2019
Q2 | – | Sell |
-1,313
| Closed | -$170K | – | 417 |
|
|
2019
Q1 | $170K | Buy |
1,313
+254
| +24% | +$30.9K | 0.03% | 171 |
|
|
2018
Q4 | $123K | Hold |
1,059
| – | – | 0.02% | 182 |
|
|
2018
Q3 | $114K | Sell |
1,059
-26
| -2% | -$2.6K | 0.02% | 194 |
|
|
2018
Q2 | $93K | Sell |
1,085
-155
| -13% | -$12.7K | 0.02% | 261 |
|
|
2018
Q1 | $96K | Buy |
1,240
+180
| +17% | +$14.5K | 0.02% | 287 |
|
|
2017
Q4 | $90K | Buy |
1,060
+27
| +3% | +$2.3K | 0.01% | 292 |
|
|
2017
Q3 | $88K | Buy |
1,033
+95
| +10% | +$7.79K | 0.01% | 280 |
|
|
2017
Q2 | $77K | Sell |
938
-206
| -18% | -$16.8K | 0.02% | 282 |
|
|
2017
Q1 | $96K | Buy |
1,144
+23
| +2% | +$1.84K | 0.02% | 267 |
|
|
2016
Q4 | $82K | Buy |
1,121
+400
| +55% | +$29.8K | 0.01% | 196 |
|
|
2016
Q3 | $58K | Hold |
721
| – | – | 0.01% | 213 |
|
|
2016
Q2 | $57K | Buy |
721
+161
| +29% | +$12.1K | 0.01% | 242 |
|
|
2016
Q1 | $40K | Sell |
560
-9,349
| -94% | -$707K | 0.01% | 270 |
|
|
2015
Q4 | $835K | Sell |
9,909
-452
| -4% | -$37.5K | 0.18% | 110 |
|
|
2015
Q3 | $867K | Buy |
10,361
+2,839
| +38% | +$240K | 0.19% | 114 |
|
|
2015
Q2 | $628K | Buy |
7,522
+660
| +10% | +$50.3K | 0.12% | 130 |
|
|
2015
Q1 | $499K | Buy |
6,862
+335
| +5% | +$23.9K | 0.07% | 129 |
|
|
2014
Q4 | $450K | Buy |
6,527
+920
| +16% | +$62.1K | 0.07% | 113 |
|
|
2014
Q3 | $364K | Buy |
5,607
+965
| +21% | +$61.1K | 0.06% | 114 |
|
|
2014
Q2 | $289K | Buy |
4,642
+1,245
| +37% | +$74.3K | 0.05% | 160 |
|
|
2014
Q1 | $200K | Buy |
3,397
+322
| +10% | +$18K | 0.04% | 151 |
|
|
2013
Q4 | $157K | Sell |
3,075
-495
| -14% | -$24.8K | 0.03% | 152 |
|
|
2013
Q3 | $180K | Buy |
3,570
+900
| +34% | +$47.1K | 0.03% | 143 |
|
|
2013
Q2 | $131K | Buy |
+2,670
| New | +$145K | 0.03% | 146 |
|
Other funds holding LLY
Dubuque Bank & Trust's LLY Position: Q3 2023 in Review
Dubuque Bank & Trust increased its Eli Lilly (LLY) stake by 13% in Q3 2023, buying an estimated $90.7K and bringing the position to 1,510 shares worth $811K. The position accounts for 0.11% of the portfolio, ranked #95.
Dubuque Bank & Trust first reported a position in LLY in Q2 2013 and has held it in 37 quarters since. The position peaked at $867K in Q3 2015. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.
- Dubuque Bank & Trust held 1,510 shares of Eli Lilly worth $811K as of Q3 2023.
- Dubuque Bank & Trust bought 176 Eli Lilly shares in Q3 2023, an estimated $90.7K.
- Eli Lilly made up 0.11% of Dubuque Bank & Trust's portfolio in Q3 2023, its #95 holding.
- Dubuque Bank & Trust first reported a position in Eli Lilly in Q2 2013 and has held it in 37 quarters since.
- Dubuque Bank & Trust's Eli Lilly position peaked at $867K in Q3 2015.
- 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.
Based on Dubuque Bank & Trust's 13F filing for Q3 2023, filed 27 Oct 2023.